CD274 and neoplasm: Several molecular characteristics are associated with rare histologies, namely the frequency of biomarkers related to immunotherapy benefits, such as Tumor-Mutational-Burden (TMB), Microsatellite Instability (MSI), PD-L1 gene amplification, and IHC staining of the latter (75).